ADAM metallopeptidase with thrombospondin type 1 motif 3
| GO Term | Evidence Code | PMID |
|---|---|---|
| in utero embryonic development |
|
|
| proteolysis |
|
|
| proteolysis |
|
|
| integrin-mediated signaling pathway |
|
|
| vascular endothelial growth factor production |
|
| GO Term | Evidence Code | PMID |
|---|---|---|
| extracellular region |
|
|
| extracellular region |
|
|
| extracellular region |
|
|
| extracellular region |
|
|
| obsolete extracellular space |
|
|
| GO Term | Evidence Code | PMID |
|---|---|---|
| endopeptidase activity |
|
|
| metalloendopeptidase activity |
|
|
| metalloendopeptidase activity |
|
|
| metalloendopeptidase activity |
|
|
| metalloendopeptidase activity |
|
| Gene Ontology |
|---|
| extracellular matrix organization |
| metal ion binding |
| metalloendopeptidase activity |
| metallopeptidase activity |
| proteolysis |
| DO ID | Disease Name | Source |
|---|---|---|
| DOID:0060366 | Hennekam syndrome |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.5.0
Last updated: April 6, 2026